EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:753678 - siplizumab
| ChEBI ID | CHEBI:753678 |
| ChEBI Name | siplizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Applications: | renoprotective agent Any compound that is able to prevent damage to the kidneys. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. hypoglycemic agent A drug which lowers the blood glucose level. antipsoriatic A drug used to treat psoriasis. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| siplizumab (CHEBI:753678) has role anti-anaemic agent (CHEBI:75835) |
| siplizumab (CHEBI:753678) has role antineoplastic agent (CHEBI:35610) |
| siplizumab (CHEBI:753678) has role antipsoriatic (CHEBI:50748) |
| siplizumab (CHEBI:753678) has role hypoglycemic agent (CHEBI:35526) |
| siplizumab (CHEBI:753678) has role renoprotective agent (CHEBI:231911) |
| siplizumab (CHEBI:753678) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| siplizumab | WHO MedNet |
| Synonym | Source |
|---|---|
| MEDI-507 | ChEMBL |